Literature DB >> 35723813

Evidence-Based Dampness-Heat ZHENG (Syndrome) in Cancer: Current Progress toward Establishing Relevant Animal Model with Pancreatic Tumor.

Ju-Ying Jiao1,2, Chien-Shan Cheng1,2, Zhang-Qi Cao1,2, Lian-Yu Chen1,2, Zhen Chen3,4.   

Abstract

Cancer is one of the deadliest diseases affecting the health of human beings. With limited therapeutic options available, complementary and alternative medicine has been widely adopted in cancer management and is increasingly becoming accepted by both patients and healthcare workers alike. Chinese medicine characterized by its unique diagnostic and treatment system is the most widely applied complementary and alternative medicine. It emphasizes symptoms and ZHENG (syndrome)-based treatment combined with contemporary disease diagnosis and further stratifies patients into individualized medicine subgroups. As a representative cancer with the highest degree of malignancy, pancreatic cancer is traditionally classified into the "amassment and accumulation". Emerging perspectives define the core pathogenesis of pancreatic cancer as "dampness-heat" and the respective treatment "clearing heat and resolving dampness" has been demonstrated to prolong survival in pancreatic cancer patients, as has been observed in many other cancers. This clinical advantage encourages an exploration of the essence of dampness-heat ZHENG (DHZ) in cancer and investigation into underlying mechanisms of action of herbal formulations against dampness-heat. However, at present, there is a lack of understanding of the molecular characteristics of DHZ in cancer and no standardized and widely accepted animal model to study this core syndrome in vivo. The shortage of animal models limits the ability to uncover the antitumor mechanisms of herbal medicines and to assess the safety profile of the natural products derived from them. This review summarizes the current research on DHZ in cancer in terms of the clinical aspects, molecular landscape, and animal models. This study aims to provide comprehensive insight that can be used for the establishment of a future standardized ZHENG-based cancer animal model.
© 2022. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chinese medicine syndrome; ZHENG; animal model; cancer; dampness-heat syndrome; evaluation methods; pancreatic tumor

Year:  2022        PMID: 35723813     DOI: 10.1007/s11655-022-3675-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  43 in total

1.  Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome.

Authors:  Yue Chen; Ting-hui Jiang; Wei-zhe Ru; Ai-wu Mao; Yan Liu
Journal:  Chin J Integr Med       Date:  2014-06-10       Impact factor: 1.978

2.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

3.  The molecular mechanisms of traditional Chinese medicine ZHENG syndromes on pancreatic tumor growth.

Authors:  Hai-Yan Dai; Peng Wang; Lan-Yun Feng; Lu-Ming Liu; Zhi-Qiang Meng; Xiao-Yan Zhu; Kun Wang; Yong-Qiang Hua; Yi-Xiang Mao; Lian-Yu Chen; Zhen Chen
Journal:  Integr Cancer Ther       Date:  2010-08-11       Impact factor: 3.279

4.  Plasma metabolic profiling on postoperative colorectal cancer patients with different traditional Chinese medicine syndromes.

Authors:  Xue-Qing Hu; Bin Wei; Ya-Nan Song; Qing Ji; Qi Li; Yun-Quan Luo; Wen-Hai Wang; Shi-Bing Su
Journal:  Complement Ther Med       Date:  2017-11-13       Impact factor: 2.446

5.  Traditional Chinese Medicine symptom patterns in patients with colorectal carcinoma.

Authors:  Yan Li; Jianzhong Gu; Huamiao Zhou; Weihong Yang; Yong Guo; Hui Wang; Ying Zou
Journal:  J Tradit Chin Med       Date:  2018-04       Impact factor: 0.848

6.  Traditional chinese medicine zheng in the era of evidence-based medicine: a literature analysis.

Authors:  Miao Jiang; Chi Zhang; Guang Zheng; Hongtao Guo; Li Li; Jing Yang; Cheng Lu; Wei Jia; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-06       Impact factor: 2.629

7.  Clinical Distribution and Molecular Basis of Traditional Chinese Medicine ZHENG in Cancer.

Authors:  Zhen Chen; Peng Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-04       Impact factor: 2.629

8.  TAM Infiltration Differences in "Tumor-First" and " ZHENG-First" Models and the Underlying Inflammatory Molecular Mechanism in Pancreatic Cancer.

Authors:  Feng-Jiao Wang; Peng Wang; Lian-Yu Chen; Ya-Wen Geng; Hao Chen; Zhi-Qiang Meng; Lu-Ming Liu; Zhen Chen
Journal:  Integr Cancer Ther       Date:  2018-04-22       Impact factor: 3.279

9.  Molecular profiling analysis for colorectal cancer patients with Pi-Xu or Shi-Re syndrome.

Authors:  Xinbing Sui; Yong Guo; Wei Ni; Haiyan Jin; Haoming Lin; Tian Xie
Journal:  Integr Med Res       Date:  2018-11-24

10.  Patient Reported Traditional Chinese Medicine Spleen Deficiency Syndrome (TCM-SDS) Scale for Colorectal Cancer: Development and Validation in China.

Authors:  Lingyun Sun; Jun J Mao; Yunzi Yan; Yun Xu; Yufei Yang
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.